Stock & Company Details
Amneal Pharmaceuticals Inc $AMRX
Price:
N/A
N/A
319M
$6.8B
52 Week High:
N/A
10 Day Average Volume:
N/A
52.68
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
AMRX technical indicators
Latest Amneal Pharmaceuticals Inc (AMRX) indicator readings as of 2026-10-08.
AMRX's 14-day RSI is 55.7, in neutral territory. ADX reads 29.0, indicating a trending market. MACD (12, 26, 9) is 0.57, above the zero line.
AMRX backtested strategy results
How 4 rule-based strategies performed on Amneal Pharmaceuticals Inc (AMRX) over recent history, last backtested 2026-10-07. Select a strategy to plot its trades on the chart above. Past performance does not predict future results.
| Strategy | Equity curve | Return | Win rate | Trades | Max drawdown |
|---|---|---|---|---|---|
| Oversold Bounce Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | +41.0% | 44% | 9 | -53.0% | |
| Momentum Crossover Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | +39.7% | 24% | 33 | -72.3% | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | -47.0% | 24% | 38 | -66.9% | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | +95.7% | 67% | 24 | -43.0% |
Overview
Amneal Pharmaceuticals Inc is a generic pharmaceutical manufacturer. The company's reportable segments are Generic Products, Specialty products, and AvKARE. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products, and transdermals, and the Specialty segment is engaged in the development, promotion, sale and distribution of proprietary branded pharmaceutical products. The AvKARE segment provides pharmaceuticals, medical and surgical products, and services primarily to governmental agencies.
Finance Bot
Ask your questions
Start by typing a question below.
